Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2011
Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancerX He, F J Esteva, J Ensor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Safety and efficacy of bisphosphonates beyond 24 months in cancer patientsS M Ali, F J Esteva, G Hortobagyi, et al.
Skeletal Radiology|October 1, 1994
Case report 866. Pseudotumor of the muscle associated with necrotizing vasculitis of medium- and small-sized arteries and chronic myositisF J Esteva-Lorenzo, J L Ferreiro, F Tardaguila, et al.
Oncogene|December 1, 2009
Calpain regulates sensitivity to trastuzumab and survival in HER2-positive breast cancerS Kulkarni, K B Reddy, F J Esteva, et al.
Cancer|October 1, 1995
Myositis associated with interleukin-2 therapy in a patient with metastatic renal cell carcinomaF J Esteva-Lorenzo, J E Janik, R G Fenton, et al.
Cancer Chemotherapy and Pharmacology|December 29, 2000
Phase II trial and pharmacokinetic evaluation of cytosine arabinoside for leptomeningeal metastases from breast cancerF J Esteva, L T Soh, F A Holmes, et al.
British Journal of Cancer|January 10, 2013
Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomasY Delpech, C Coutant, L Hsu, et al.
NPJ Breast Cancer|January 15, 2020
LncRNA RP11-19E11 is an E2F1 target required for proliferation and survival of basal breast cancerA Giro-Perafita, L Luo, A Khodadadi-Jamayran, et al.
Pathology Oncology Research : POR|November 3, 2001
Expression of erbB/HER receptors, heregulin and P38 in primary breast cancer using quantitative immunohistochemistryF J Esteva, G N Hortobagyi, A A Sahin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2012
Association between the nuclear to cytoplasmic ratio of p27 and the efficacy of adjuvant polychemotherapy in early breast cancerF Andre, R Conforti, C B Moeder, et al.
Pageof 3